To conclude, our findings show that bimodal NIRF/PA imaging using EpCAM-binding DARPin tracers Ac2-800CW and Ec4.1-800CW allows for clear colon tumor delineation at a rapid and clinically practical time window of 24 h post-injection. The gene discussed is EPCAM; the disease is colonic neoplasm.